Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-156612
Filing Date
2016-12-23
Accepted
2016-12-23 06:12:25
Documents
1
Period of Report
2016-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4880
  Complete submission text file 0001209191-16-156612.txt   6233
Mailing Address 1 STULTS DRIVE PLAINSBORO NJ 08536
Business Address
CAUWENBERGH GEERT (Reporting) CIK: 0001285648 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 162067895

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations